Under construction – not a live service
Sign in

What researchers published on Neuromyelitis optica (NMOSD)

532 papers, newest first.

Showing 40 of 532

  • Not labelled yetDiscontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies.Neurology(R) neuroimmunology & neuroinflammation
  • Not labelled yetCortical Hierarchical Disorganization and Transcriptomic Associations in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders Revealed by Morphometric INverse Divergence Network Gradients.CNS neuroscience & therapeutics
  • Case reportDiagnostic dilemma in the management of a cervical spinal cord lesion: neuromyelitis optica spectrum disorder: a case report.Journal of medical case reports
  • Not labelled yetBiologic switching and relapses during biologic therapy in AQP4-IgG-positive NMOSD: a real-world study.Multiple sclerosis and related disorders
  • Case reportIntractable Nausea and Vomiting: A Key Feature of Neuromyelitis Optica Spectrum Disorder.The American journal of case reports
  • PreprintInnate Immune Dysregulation Precedes Clinical Onset in Neuromyelitis Optica.bioRxiv : the preprint server for biology
  • Not labelled yetPregnancy and Disease Activity in AQP4+ Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Multicenter Turkish Cohort.Noro psikiyatri arsivi
  • Case reportNeuromyelitis optica spectrum disorder presenting as rapidly progressive dementia: A case report.Medicine
  • ReviewRole of microglia in neuromyelitis optica (Review).International journal of molecular medicine
  • Not labelled yetA Case Report of Early Multimodal Immunotherapy for Rapidly Progressive Neuromyelitis Optica Spectrum Disorder with Extensive Brain Lesions.Internal medicine (Tokyo, Japan)
  • Not labelled yetPhenotypic and immunological profile divergence between SLE-associated myelitis and SLE-NMOSD overlap syndrome: a retrospective case series.Frontiers in immunology
  • Not labelled yetAssociation between psychosocial consequences of visual dysfunction and depressive symptom burden in multiple sclerosis and neuromyelitis optica spectrum disorder.Frontiers in neurology
  • Not labelled yetAQP4 antibody-induced astrocyte injury reshapes CNS immune architecture in a combined EAE-AQP4-IgG model of neuromyelitis optica spectrum disorder.Frontiers in immunology
  • Not labelled yetProportion and Clinical Characteristics of Double-Seronegative NMOSD in a Multicenter Real-World Cohort.European journal of neurology
  • Case reportCerebral Air Embolism After Double-lumen Catheter Removal for Plasmapheresis: A Case Report.Acta neurologica Taiwanica
  • Not labelled yetPhase-associated differences in perivascular and glymphatic-related MRI markers in AQP4-IgG-seropositive neuromyelitis Optica spectrum disorder: A cross-sectional study.Multiple sclerosis and related disorders
  • ReviewLatin American consensus recommendations on the role of magnetic resonance imaging in neuromyelitis optica spectrum disorder in clinical practice.Multiple sclerosis and related disorders
  • Not labelled yetCharacteristics of serum Metrnl levels in patients with neuromyelitis optica spectrum disorder and their associations with disease activity and inflammatory biomarkers.Frontiers in immunology
  • Not labelled yetEfficacy of Fampridine on Refractory Optic Neuritis in Neuromyelitis Optica Spectrum Disorders.Annals of clinical and translational neurology
  • Not labelled yetEfficacy and Safety of Multidisciplinary Sandwich Regimen in AQP4-IgG+ NMOSD With Preconception B-Cell Depletion During Perigravidity.CNS neuroscience & therapeutics
  • Not labelled yetIsolated Extramedullary Trigeminal Nerve Root Lesion in Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 Immunoglobulin G.The Neurohospitalist
  • Not labelled yetAltered intersubject variability of functional connectivity in gray and white matter underlying neurocognition and genetic profiles in neuromyelitis optica spectrum disorder.Neural regeneration research
  • ReviewThe Balance Between Immune Activation and Tolerance in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders and MOG Antibody-Associated Disease.Immunology and cell biology
  • Observational studyRavulizumab in neuromyelitis optica spectrum disorder: first clinical experience in Chile.Frontiers in immunology
  • Not labelled yetInvestigation of Complement Activation and Cytokine Signatures in AQP4+ NMOSD, MOGAD, and MS.Annals of clinical and translational neurology
  • Not labelled yetSoluble TIM-3 and galectin-9 in cerebrospinal fluid are associated with disability at 6 months in aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder.Frontiers in immunology
  • Not labelled yetProgressive hemifacial atrophy, AQP4-positive NMOSD and suspected Sjögren's syndrome: five-year relapse-free follow-up during rituximab therapy.Acta neurologica Belgica
  • Not labelled yetDifferential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4 + NMOSD: The Role of Disease Activity in MOGAD.Neurology
  • Not labelled yetCharacterization of distinct cognitive domain patterns in AQP4-IgG-positive NMOSD: A MoCA-based factor analysis and risk profiling.Multiple sclerosis and related disorders
  • Not labelled yetIncreased autoimmune disease burden before multiple sclerosis and neuromyelitis optica spectrum disorder diagnosis: A nationwide Korean cohort study.Multiple sclerosis (Houndmills, Basingstoke, England)
  • ReviewRecognizing and Differentiating Area Postrema Syndrome Across NMOSD, MOGAD, and GFAP Astrocytopathy.International journal of molecular sciences
  • Not labelled yetCo-occurrence of myasthenia gravis and neuromyelitis optica spectrum disorder: A case series and literature review.Journal of neuroimmunology
  • Not labelled yetNOP58 knockdown in microglia is associated with reduced neuroinflammation and synaptic damage in NMOSD.Journal of neuroimmunology
  • Not labelled yetClinical phenotype and treatment response in AQP4-IgG-positive NMOSD and MOGAD: insights from the Italian I-MS&RD registry.Journal of neurology
  • Not labelled yetUtility of Blood Neutrophil to Diagnose Bacterial Infections under Satralizumab Treatment for Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Report of Two Cases.Internal medicine (Tokyo, Japan)
  • ReviewWhy repair fails in AQP4-IgG-positive neuromyelitis optica spectrum disease: an astrocyte-centered framework for remyelination and neuroaxonal preservation.Frontiers in immunology
  • Not labelled yetNutritional Status in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.Journal of clinical medicine research
  • Not labelled yetBeyond physical disability: the case for systematic mental health screening in the care of NMOSD and MOGAD in Latin America.Multiple sclerosis and related disorders
  • Not labelled yetCerebral Attack With Cortical-Leptomeningeal Involvement and Seizures in AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.Internal medicine (Tokyo, Japan)
  • Not labelled yetCase Report: Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder: Diagnostic Challenges and Transition From B-Cell Depletion Therapy to Ravulizumab.Clinical case reports